MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0064928
Rindz Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.98 Cr
▲ 16% YoY
Net loss · FY 2025
₹42,637
Net margin -0.1%
EBITDA · FY 2025
₹14.03 Lakh
EBITDA margin 2.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹52.98 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
12
Provident fund records
About Rindz Pharma Private Limited
Data last updated:
Rindz Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2018PTC123985. Its GSTIN is 33AAJCR0761R1ZW (Tamil Nadu).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajeswaran Gowri and Narmadha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 174 9 The Street Porur Gardens Phase 1, Chennai, Tamil Nadu, India – 600095.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.98 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹42,637 (net margin -0.1%) and EBITDA of ₹14.03 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 23% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹52.98 Lakh on record.
Rindz Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0064928). For more details, the company can be reached via its website rindz.co.in.
Company details
CIN U51909TN2018PTC123985
Registration Number 123985
Incorporation Date 06 August 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0064928
Recognitions & Rankings of Rindz Pharma
Contact details
Rindz Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is rindz.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 174 9 The Street Porur Gardens Phase 1, Chennai, Tamil Nadu, India – 600095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rindz Pharma Private Limited, buy the company report.
Comprehensive company report
Rindz Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rindz Pharma is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Rindz Pharma Private Limited, buy the company report.
Financials of Rindz Pharma Private Limited
FY 2025 filings availableRindz Pharma Private Limited reported revenue of ₹4.98 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹4.98 Cr ▲ 16%
Net loss · FY 2025
₹42,637 margin -0.1%
EBITDA · FY 2025
₹14.03 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 30%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▲ 10%
5 years · compounded
▼ 27%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 16% growth in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹42,637 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rindz Pharma Private Limited, buy the company report.
Board of directors of Rindz Pharma Private Limited
Rindz Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeswaran Gowri | Director | 06 Aug 2018 | 8 Years 2 Months | Current |
| Narmadha | Director | 13 Jun 2019 | 7 Years 4 Months | Current |
| Shanmugam Rajeswaran | Director | 06 Aug 2018 | 8 Years 2 Months | Current |
Auditor
Rindz Pharma Private Limited is audited by SENTHIL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SENTHIL & ASSOCIATES | FY 2021 | 013655S |
Shareholding
The shareholding of Rindz Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rindz Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹52.98 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Feb 2024 | 100885118 | Indian Bank | ₹29.5 Lakh | Open | |
| 25 Jul 2023 | 100790849 | Hdfc Bank Limited | ₹23.48 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rindz Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rindz Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rindz Pharma Private Limited has a workforce of 12 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
GST
Rindz Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAJCR0761R1ZW | Tamil Nadu | Active | 18 Aug 2018 |
To see the full GST registrations and return filing status of Rindz Pharma Private Limited, buy the company report.
Recent activity
Rindz Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Narmadha was appointed as Director on 13 Jun 2019.
AGM
Rindz Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rindz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Indian Bank amounted to Rs. 29.50 Lakh with Charge ID 100885118 was registered on 22 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.48 Lakh with Charge ID 100790849 was registered on 25 Jul 2023.
Appointed
Narmadha was appointed as Director.
Appointed
Rajeswaran Gowri was appointed as Director.
Appointed
Shanmugam Rajeswaran was appointed as Director.
Incorporation
06 Aug 2018
Rindz Pharma Private Limited was registered on 06 Aug 2018 with Roc Chennai & aged 8 years 3 months as per MCA records.
Frequently asked questions
Rindz Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 August 2018 (8+ years old) and is registered under CIN U51909TN2018PTC123985.
Rindz Pharma has 3 current directors:
- Rajeswaran Gowri - Director
- Narmadha - Director
- Shanmugam Rajeswaran - Director
The latest financial statements of Rindz Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rindz Pharma is 33AAJCR0761R1ZW, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Rindz Pharma is U51909TN2018PTC123985. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rindz Pharma was incorporated on 06 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Narmadha was appointed as Director on 13 Jun 2019. Rajeswaran Gowri was appointed as Director on 06 Aug 2018. Shanmugam Rajeswaran was appointed as Director on 06 Aug 2018.
Yes, Rindz Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0064928).
Rindz Pharma can be reached through the website rindz.co.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Rindz Pharma is at Plot No. 174 9 The Street Porur Gardens Phase 1, Chennai, Tamil Nadu, India – 600095.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages